Healthcare

The American healthcare industry is in the midst of major changes. The passage and ongoing implementation of the Affordable Care Act has led to the most sweeping changes to the healthcare industry since the establishment of Medicare.

Undoubtedly, there will be significant changes to an already stressed industry as medical providers, insurers, and patients all adjust to the evolving marketplace. Revenue management, in combination with aggressive cost controlling, will be even more essential for the healthcare industry. Further consolidation in the industry is expected. Companies that are not prepared for these new dynamics will face unprecedented challenges to their business models.

As the leader in healthcare transactions and restructurings, Conway MacKenzie has been active in the healthcare industry since our formation. Our approach to working with companies in the healthcare industry follows the same model across the rest of our industry experience: teams of seasoned professionals that combine deep healthcare expertise and technical acumen with an execution-focused action plan to drive long-term sustainable solutions.

Conway MacKenzie’s Healthcare Group has extensive industry knowledge, including past engagement experience related to:

Hospitals
Long Term Care and Skilled Nursing Facilities
Managed Care Organizations (MCOs)
Independent Delivery Networks (IDNs)
Specialty Medical and Outpatient Clinics
Home Healthcare Companies
Medical Device and Equipment Manufacturers and Distributors
Medical Transportation Companies
Nonprofit Healthcare Foundations
Healthcare-Related Valuation Engagements and Litigation Matters

View Select Case Studies

A Top to Bottom Diagnosis

The Engagement

With combined revenue exceeding $7 billion, Conway MacKenzie completed a comprehensive quality of earnings review, business plan validation and quantification and validation of the combined synergies initially identified.

Our Role

Conway MacKenzie’s team of professionals evaluated the baseline plans of these systems, which included an approximate $2.5 billion health insurance entity, as well as overlaying the contemplated impact of the Patient Protection and Affordable Care Act (PPACA) and other industry developments on the long-term financial plan.

The Result

This merger analysis, along with other information and work product, was used by the respective executive leadership teams and board of trustees to evaluate the merits of the proposed merger and determine appropriate next steps.

The Engagement

Our Role

The Result

Industry Professionals